A relatively old drug -- metformin -- may hold the key to preventing life-threatening illness and bolstering human longevity, ...

New research reveals that metformin’s power may start in the brain, reshaping our understanding of blood sugar control and ...

Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...

New treatment combines DPP-4 inhibitor, linagliptin (the active ingredient in Tradjenta™ (linagliptin) tablets), and metformin in a single tablet, taken twice-daily, to lower blood sugar in adults ...

Metformin tablets are used to treat type 2 diabetes and are designed to lower glucose levels. The recall applies to metformin tablets between 500 mg and 750 mg, sold under the brand name Time-Cap ...

Several scientific studies show that the common diabetes drug Metformin can protect against dementia and Alzheimer’s.

The recall applies to metformin tablets ranging between 500 milligrams and 750 milligrams, which are sold under the brand name Time-Cap Labs, Inc., reported CNN Health.

Metformin is used for managing blood glucose in adults with Type 2 diabetes mellitus. The recalled diabetes medication was packaged in HDPE bottles of 100 tablets under the NCD 72578-036-01.

Use of firstline type 2 diabetes medication, metformin, has been linked to a lower risk of dementia in obese patients. | Drug ...

Lilly undertakes no duty to update forward-looking statements. P-LLY JD351100 1. Jentadueto® (linagliptin/metformin HCl) tablets. EMA Summary of Product Characteristics. 2012 2.